does medicare pay for glp 1 Majesta GLP-1's and Medicare - MP
Description
Eli Lilly and a handful of giant companies
These therapies are increasingly recognized for their benefits in managing cardiovascular, renal, and metabolic conditions, which are common comorbidities among patients with T2D
But the manufacturer offers rebates that can bring down the cost to about $499 a month, as long as patients pay out of pocket without using insurance
Schedule your visit today
In a retrospective cohort study, the researchers used data of 27 279 patients with type 2 diabetes and stage 5 CKD or ESKD from the National Health Insurance Research Database of Taiwan
